ZA200800125B - Promotion of epithelial regeneration - Google Patents

Promotion of epithelial regeneration

Info

Publication number
ZA200800125B
ZA200800125B ZA200800125A ZA200800125A ZA200800125B ZA 200800125 B ZA200800125 B ZA 200800125B ZA 200800125 A ZA200800125 A ZA 200800125A ZA 200800125 A ZA200800125 A ZA 200800125A ZA 200800125 B ZA200800125 B ZA 200800125B
Authority
ZA
South Africa
Prior art keywords
promotion
epithelial regeneration
epithelial
regeneration
Prior art date
Application number
ZA200800125A
Other languages
English (en)
Inventor
Ferguson Mark
Laverty Hugh
O'kane Sharon
Occleston Nick
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of ZA200800125B publication Critical patent/ZA200800125B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA200800125A 2005-07-12 2008-01-04 Promotion of epithelial regeneration ZA200800125B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0514262.5A GB0514262D0 (en) 2005-07-12 2005-07-12 Promotion of epithelial regeneration

Publications (1)

Publication Number Publication Date
ZA200800125B true ZA200800125B (en) 2008-12-31

Family

ID=34897090

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800125A ZA200800125B (en) 2005-07-12 2008-01-04 Promotion of epithelial regeneration

Country Status (12)

Country Link
US (1) US20080207515A1 (de)
EP (2) EP1904089A2 (de)
JP (1) JP2009501201A (de)
KR (1) KR20080031405A (de)
CN (1) CN101252949A (de)
AU (1) AU2006268091C1 (de)
BR (1) BRPI0613127A2 (de)
CA (1) CA2614758A1 (de)
GB (1) GB0514262D0 (de)
IL (1) IL188351A0 (de)
WO (1) WO2007007098A2 (de)
ZA (1) ZA200800125B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0514262D0 (en) 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration
GB0604966D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0724203D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for the inhibition of scarring
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
GB0910078D0 (en) * 2009-06-11 2009-07-22 Renovo Ltd Uses of mannose-6-phosphate
KR101908445B1 (ko) 2010-11-12 2018-10-17 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. 변형된 면역-조절 입자
RU2669346C2 (ru) 2012-06-21 2018-10-10 Норсвестерн Юниверсити Частицы, конъюгированные с пептидами
KR20230025948A (ko) 2013-03-13 2023-02-23 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. 염증 치료용 면역-변형된 입자
DK3033102T4 (da) 2013-08-13 2024-02-26 Univ Northwestern Peptidkonjugerede partikler
WO2015138502A1 (en) * 2014-03-11 2015-09-17 Gary Cleary In-situ skin regeneration for epidermolysis bullosa and other skin disorders
US10584344B2 (en) * 2014-06-17 2020-03-10 Crown Laboratories, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
KR102313197B1 (ko) * 2018-07-11 2021-10-18 강형철 고체상염의 삼투작용으로 수포형성을 억제하는 화상 응급처치용 치료 제제 및 이를 포함하는 패치
WO2022243702A1 (en) 2021-05-21 2022-11-24 Emblation Limited Microwave treatment of tissue

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051848A (en) * 1976-03-01 1977-10-04 Levine Norman S Synthetic skin wound dressing
US6559123B1 (en) * 1985-04-19 2003-05-06 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
NZ222168A (en) 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
AU3943793A (en) * 1992-04-01 1993-11-08 Whittier Institute For Diabetes And Endocrinology, The Methods of inhibiting or enhancing scar formation in the CNS
US5411940A (en) * 1993-09-29 1995-05-02 Alcon Laboratories, Inc. Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
EP1074620A1 (de) * 1999-08-06 2001-02-07 HyGene AG Monomer Protein der TGF-beta Familie
EP1161257A2 (de) * 1999-03-17 2001-12-12 Novartis AG Tgf-beta enthaltende pharmazeutische zusammensetzungen
EP1279677B1 (de) * 2000-04-25 2007-03-07 Otsuka Pharmaceutical Co., Ltd. Gd3 mimetische peptide
US20040078851A1 (en) * 2000-05-02 2004-04-22 Ning Huang Production of human growth factors in monocot seeds
JP2004525930A (ja) * 2001-03-23 2004-08-26 バイオファーム・ゲゼルシャフト・ツア・バイオテクノロジシェン・エントヴィックルング・フォン・ファーマカ・ミット・ベシュレンクテル・ハフツング 皮膚関連疾患の治療及び診断のためのＴＧＦ−βスーパーファミリーのサイトカインの使用
EP1915169A2 (de) * 2005-07-12 2008-04-30 Renovo Limited Pharmazeutische zusammensetzungen mit einem tgf-beta superfamilien-mitglied
GB0514262D0 (en) 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration

Also Published As

Publication number Publication date
WO2007007098A2 (en) 2007-01-18
CN101252949A (zh) 2008-08-27
EP2298336A3 (de) 2011-07-13
AU2006268091A1 (en) 2007-01-18
JP2009501201A (ja) 2009-01-15
AU2006268091C1 (en) 2011-03-31
KR20080031405A (ko) 2008-04-08
GB0514262D0 (en) 2005-08-17
EP2298336A2 (de) 2011-03-23
IL188351A0 (en) 2008-04-13
CA2614758A1 (en) 2007-01-18
US20080207515A1 (en) 2008-08-28
EP1904089A2 (de) 2008-04-02
EP2298336A9 (de) 2011-06-01
AU2006268091B2 (en) 2010-09-02
WO2007007098A3 (en) 2007-05-18
BRPI0613127A2 (pt) 2010-12-21

Similar Documents

Publication Publication Date Title
IL188351A0 (en) Promotion of epithelial regeneration
GB0712735D0 (en) Dressing
ZA200708563B (en) Nebuliser
IL194236A0 (en) Antibody purification
IL186492A0 (en) Nebuliser
EP1850873A4 (de) Antikörper gegen tgfbeta
GB0610553D0 (en) Dressing
PT2011869E (pt) Novo anticorpo anti-cd98
EP1869192A4 (de) Rahmenmischung von antikörpern
GB0611116D0 (en) Proteins
IL185757A0 (en) Methods of decreasing calcifcation
GB0601976D0 (en) Proteins
GB0620735D0 (en) Proteins
DE502006007368D1 (de) Fördervorrichtung
DE602005013361D1 (de) Pneumatischer filter
EP2121726A4 (de) Proteinpartikel
EP2024516A4 (de) Perforin-2-proteine
GB0623196D0 (en) Dressing
GB0606021D0 (en) Discharge lamp
GB0518232D0 (en) New methods
GB0614682D0 (en) Proteins
GB0612623D0 (en) Proteins
GB0501638D0 (en) Particulates
AU2005906217A0 (en) Methods for Promotion
SE0401263D0 (sv) New particles